MeadowBrook Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Sell
9,874
-215
-2% -$19.2K 0.81% 33
2026
Q1
$725K Buy
10,089
+50
+0.5% +$3.85K 0.64% 44
2025
Q4
$797K Sell
10,039
-170
-2% -$13.4K 0.68% 37
2025
Q3
$770K Sell
10,209
-140
-1% -$9.6K 0.66% 41
2025
Q2
$714K Sell
10,349
-85
-0.8% -$5.57K 0.64% 41
2025
Q1
$707K Sell
10,434
-380
-4% -$22.7K 0.66% 38
2024
Q4
$485K Sell
10,814
-3,797
-26% -$213K 0.43% 56
2024
Q3
$919K Sell
14,611
-256
-2% -$14.9K 0.83% 32
2024
Q2
$878K Buy
14,867
+685
+5% +$42.8K 0.83% 33
2024
Q1
$1.13M Sell
14,182
-355
-2% -$27.1K 1.05% 27
2023
Q4
$1.15M Buy
+14,537
New +$1.03M 1.1% 26

Other funds holding CVS

MeadowBrook Investment Advisors's CVS Position: Q2 2026 in Review

MeadowBrook Investment Advisors reduced its CVS Health (CVS) stake by 2.1% in Q2 2026, selling an estimated $19.2K and leaving 9,874 shares worth $1.02M. The position accounts for 0.81% of the portfolio, ranked #33.

MeadowBrook Investment Advisors first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.15M in Q4 2023. 567 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • MeadowBrook Investment Advisors held 9,874 shares of CVS Health worth $1.02M as of Q2 2026.
  • MeadowBrook Investment Advisors sold 215 CVS Health shares in Q2 2026, an estimated $19.2K.
  • CVS Health made up 0.81% of MeadowBrook Investment Advisors's portfolio in Q2 2026, its #33 holding.
  • MeadowBrook Investment Advisors first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • MeadowBrook Investment Advisors's CVS Health position peaked at $1.15M in Q4 2023.
  • 567 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on MeadowBrook Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.